comparemela.com
  1. Home
  2. Live Updates
  3. Biosciences Investor Contact - Breaking News

Latest Breaking News On - Biosciences investor contact - Page 13 : comparemela.com

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2022 FINANCIAL RESULTS ON NOVEMBER 1, 2022

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and.

Nancy leoneLuis sanayPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsHarmony biosciencesPlymouth meetingBiosciences investor contactBiosciences media contact

HARMONY BIOSCIENCES ANNOUNCES 2022 FUNDING RECIPIENTS OF PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD PROGRAMS

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

New yorkUnited statesColumbia universityWashington heightsNancy leoneLuis sanayCorporate affairs officerWorld sleep societyInternational sleep medicine examinationWorld sleep society medicine examinationPrnewswire harmony biosciences holdings incDivision of cardiologyPublic healthPrader willi syndrome association united statesDiverse population of high school studentsDiversity leadership program

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company focused on delivering innovative.

United statesNancy leoneLuis sanayPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsFargo healthcareAnnual biopharmaWells fargo healthcare conferenceHarmony biosciencesPlymouth meetingBiosciences investor contactBiosciences media contact

HARMONY BIOSCIENCES ANNOUNCES DATE OF SECOND QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

Nancy leoneLuis sanayHarmony biosciences holdings incParagon biosciencesHarmony biosciences holdingsHarmony biosciencesPlymouth meetingBiosciences investor contactBiosciences media contact

HARMONY BIOSCIENCES PRESENTS POST-HOC ANALYSIS OF WAKIX® (PITOLISANT) PIVOTAL DATA IN ADULTS WITH HIGH BURDEN OF NARCOLEPSY SYMPTOMS

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

United statesJeffrey daynoNancy leoneLuis sanayExchange commissionDrug administrationPrnewswire harmony biosciences holdings incParagon biosciencesBiosciences holdingsAnnual meetingAssociated professional sleep societiesChief medical officerExcessive daytime sleepinessHigh burdenEpworth sleepiness scaleWakefulness test

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.